A new report from the Centers of Disease Control and Prevention (CDC) indicates China may be facing a healthcare crisis with an steep rise in the number of cases involving drug-resistant sexually-transmitted disease . . . including “super-gonorrhea.”
Up to 98 percent of bacteria samples taken from patients with the STD across 13 Chinese provinces had the ability to sidestep frontline antibiotics, according to a new CDC report.
Gonorrhea had been effectively evading medications for years, but the chief worry among researchers is that China is reporting rates of a strain resistant to one of the last remaining effective antibiotics 40 times higher than those in the US, UK, and Canada.
Gonorrhea-causing bacteria have excelled at working around antibiotics, so much so that the only remaining recommended treatment is ceftriaxone.
Join the Conversation
VIP members get the ability to comment on articles.